Plasma Amino Acids in NAFLD Patients with Obesity Are Associated with Steatosis and Fibrosis: Results from the MAST4HEALTH Study
Authors:
- Athina I. AmanatidouAAAthina I. Amanatidou
- Eleni V. MikropoulouEMEleni V. Mikropoulou
- Charalampia AmerikanouCACharalampia Amerikanou
- Maja MilanovicMMMaja Milanovic
- Stefan StojanoskiSSStefan Stojanoski
- Mladen BjelanMBMladen Bjelan
- Lucia CesariniLCLucia Cesarini
- Jonica CampoloJCJonica Campolo
- Anastasia ThanopoulouATAnastasia Thanopoulou
- Rajarshi BanerjeeRBRajarshi Banerjee
- Mary Jo KurthMKMary Jo Kurth
- Natasa MilicNatasa Milic
Open Access
- 18 August 2023
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 13 (8) , 959
Abstract
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) have been linked to changes in amino acid (AA) levels. The objective of the current study was to examine the relationship between MRI parameters that reflect inflammation and fibrosis and plasma AA concentrations in NAFLD patients. Plasma AA levels of 97 NAFLD patients from the MAST4HEALTH study were quantified with liquid chromatography. Medical, anthropometric and lifestyle characteristics were collected and biochemical parameters, as well as inflammatory and oxidative stress biomarkers, were measured. In total, subjects with a higher MRI-proton density fat fraction (MRI-PDFF) exhibited higher plasma AA levels compared to subjects with lower PDFF. The concentrations of BCAAs (p-Value: 0.03), AAAs (p-Value: 0.039), L-valine (p-Value: 0.029), L-tyrosine (p-Value: 0.039) and L-isoleucine (p-Value: 0.032) were found to be significantly higher in the higher PDFF group compared to lower group. Plasma AA levels varied according to MRI-PDFF. Significant associations were also demonstrated between AAs and MRI-PDFF and MRI-cT1, showing the potential utility of circulating AAs as diagnostic markers of NAFLD.Keywords
All Related Versions
Funding Information
- European Union’s Horizon 2020 Research and Innovation program, MAST4HEALTH (691042, T2EDK-03044, 1529)
- European Union and Greek national funds (691042, T2EDK-03044, 1529)
- Hellenic Foundation for Research and Innovation (HFRI) (691042, T2EDK-03044, 1529)
This publication has 36 references indexed in Scilit:
- Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver diseaseNature Communications, 2014
- Multiparametric magnetic resonance for the non-invasive diagnosis of liver diseaseJournal of Hepatology, 2014
- The global NAFLD epidemicNature Reviews Gastroenterology & Hepatology, 2013
- Quantitative urine amino acid analysis using liquid chromatography tandem mass spectrometry and aTRAQ® reagentsJournal of Chromatography B, 2011
- Plasma metabolomic profile in nonalcoholic fatty liver diseaseMetabolism, 2011
- A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin ResistanceCell Metabolism, 2009
- Serum Phenylalanine Concentration as a Marker of Liver Function in Obese Patients Before and After Bariatric SurgeryObesity Surgery, 2008
- The future is around the corner: Noninvasive diagnosis of progressive nonalcoholic steatohepatitisHepatology, 2008
- International Physical Activity Questionnaire: 12-Country Reliability and ValidityMedicine & Science in Sports & Exercise, 2003
- Plasma Amino Acid Levels and Insulin Secretion in ObesityNew England Journal of Medicine, 1969